All products ↓
By area ↓
By ATC classifier ↓
|The active substance:
|Indications for use:
As an adjunct to diet and exercise for patients with insulin-independent type 2 diabetes mellitus:
- if metformin or sulfonylureas monotherapy does not provide an adequate level of glycemic control;
- shifting from combination therapy to metformin and sulfonylureas.
1 tablet contains metformin hydrochloride (long-acting) 500 mg and glimepiride 1 mg or metformin hydrochloride (long-acting) 500 mg and glimepiride 2 mg; Antidiabetic drugs. The combination of oral hypoglycemic drugs.
For detailed information, please see instruction for medical use.